AstraZeneca PLC (LSE/STO/NASDAQ:LON:AZN), a pharmaceutical giant with a market capitalization of $215.44 billion and impressive gross profit margins of 82.61%, has received a recommendation for ...
Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of its 21-valent pneumococcal conjugate ...
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended 3 biosimilars and new indications for reference biologics, moving them closer to final European ...
AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Produc ...
SHANGHAI, China I 5, 2025 I Shanghai Henlius Biotech, Inc. (2696.HK) announced that its anti-PD-1 mAb, HANSIZHUANG (serplulimab, marketed as ...
The Senate Intelligence Committee signed off on Director of National Intelligence nominee Tulsi Gabbard in a 9-8 vote on Tuesday, multiple outlets reported—a significant step forward for the ...
Washington — The Senate Finance Committee advanced Robert F. Kennedy Jr.'s nomination Tuesday, moving forward with his confirmation to lead the Department of Health and Human Services after a ...
Tulsi Gabbard is set to test her odds of Senate confirmation on Tuesday as the Senate Select Committee on Intelligence considers her nomination by President Donald Trump. Gabbard, a former ...
WASHINGTON, Feb 4 (Reuters) - President Donald Trump's contentious nomination of Tulsi Gabbard as director of national intelligence cleared a major hurdle on Tuesday when a Senate committee backed ...
Companies like Microsoft, Google, Meta and Amazon selling embedded AI within proprietary consumer and ... with a wide selection of partner-supplied products can aggregate data horizontally across ...
Gabbard gained support from three key Republican senators. The Senate Intelligence Committee voted to advance former Rep. Tulsi Gabbard's nomination for director of national intelligence in a ...
LONDON -- Over the past decade, companies such as Redis, Elastic, MongoDB, and HashiCorp have abandoned their open-source license roots and switched to proprietary models. The companies cite ...